LYS — Lysogene SA Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -78.62% | ||
| Return on Equity | n/a | ||
| Operating Margin | -77.72% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | 3.59 | 13.37 | 13.37 | 3.73 | 4 | 4 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Lysogene SA is a France-based company principally engaged in the bio diagnostics and testing. The Company is focused on the gene therapy biotechnology. The Company develops treatments targeting severe genetic pathologies with central nervous system involvement and high unmet medical needs. It is specialized in the development of intracerebral gene therapy aimed at treating pathologies affecting the central nervous system, which is the main cause of neuro-degenerative disease mortality in children.
Directors
- Karen Aiach CHM (50)
- Stephane Des Aulnois CFO
- Mark Plavsic CTO
- Ralph Laufer CSO
- Marie Deneux OTH
- Michael Hocquemiller OTH
- Sophie Olivier OTH
- Samantha Parker OTH
- Carole Deffez IND (52)
- Philippe Goupit IND (66)
- Peter Lichtlen IND (52)
- David Schilansky IND (46)
- Mathieu Simon IND (65)
- Last Annual
- December 31st, 2021
- Last Interim
- June 30th, 2022
- Incorporated
- April 15th, 2009
- Public Since
- February 8th, 2017
- No. of Employees
- 23
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 17,797,984
- Address
- 18-20 rue Jacques Dulud, NEUILLY-SUR-SEINE, 92200
- Web
- https://lysogene.com/
- Phone
- +33 141430390
- Auditors
- Deloitte & Associes
Upcoming Events for LYS
Similar to LYS
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Acticor Biotech SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
FAQ
What is the Lysogene SA share price?
As of Today at 19:13 UTC, shares in Lysogene SA are trading at €0.28. This share price information is delayed by 15 minutes.
How has the Lysogene SA share price performed this year?
Shares in Lysogene SA last closed at €0.28 and the price had moved by -85.61% over the past 365 days. In terms of relative price strength the Lysogene SA share price has underperformed the FTSE Global All Cap Index by -86.68% over the past year.
What are the analyst and broker recommendations for Lysogene SA?
The overall consensus recommendation for Lysogene SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Lysogene SA dividend yield?
Lysogene SA does not currently pay a dividend.
Does Lysogene SA pay a dividend?
Lysogene SA does not currently pay a dividend.
When does Lysogene SA next pay dividends?
Lysogene SA does not currently pay a dividend.
How do I buy Lysogene SA shares?
To buy shares in Lysogene SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Lysogene SA?
As of the previous close price of €0.28, shares in Lysogene SA had a market capitalisation of .
Where are Lysogene SA shares listed?
Here are the trading details for Lysogene SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: LYS
What kind of share is Lysogene SA?
Based on an overall assessment of its quality, value and momentum Lysogene SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Lysogene SA share price forecast for 2023?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Lysogene SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lysogene SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -59.55%.
As of the last closing price of €0.28, shares in Lysogene SA were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Lysogene SA PE Ratio?
The Lysogene SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.28.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Lysogene SA?
Lysogene SA's management team is headed by:
- Karen Aiach - CHM
- Stephane Des Aulnois - CFO
- Mark Plavsic - CTO
- Ralph Laufer - CSO
- Marie Deneux - OTH
- Michael Hocquemiller - OTH
- Sophie Olivier - OTH
- Samantha Parker - OTH
- Carole Deffez - IND
- Philippe Goupit - IND
- Peter Lichtlen - IND
- David Schilansky - IND
- Mathieu Simon - IND